CDC advisers endorse Pfizer COVID boosters for younger teens
An influential government advisory panel is recommending COVID-19 boosters for younger teens. Boosters already are recommended for everyone 16 and older.
As omicron surges, FDA expands Pfizer boosters for more teens
The U.S. is expanding COVID-19 boosters as it confronts the omicron surge. The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12.
CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot due to blood clot risk
Thursday's recommendation came after government advisers reviewed new safety data about rare but potentially life-threatening blood clots linked to J&J's shot.
Pfizer confirms COVID pill’s results, effectiveness against omicron
The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.
The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.
Pfizer and its partner BioNTech said lab tests showed a booster dose increased by 25-fold the level of so-called neutralizing antibodies against omicron.
If the Centers for Disease Control and Prevention agrees, tens of millions more Americans could have three doses of protection ahead of the new year. Anyone who got the one-dose Johnson & Johnson vaccine can already get a booster.
The Biden administration is ramping up plans for vaccine manufacturing for the coming year. But developing nations have been struggling with delays and short supplies for months and will not meet their vaccination goals for this year. Drug maker Moderna…
Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.
Additional Support Provided By:
